Poliomyelitis: Causes and Prevention

Poliomyelitis, commonly referred to as polio, is a highly infectious viral disease that primarily affects children under the age of five. Despite significant strides in its eradication, it remains a concern in certain parts of the world. 

---

Causes of Poliomyelitis

Poliomyelitis is caused by the poliovirus, a member of the Enterovirus genus, which is transmitted predominantly through the fecal-oral route. The virus resides in the throat and intestinal tract of infected individuals, where it multiplies and subsequently enters the bloodstream. Environmental factors, such as poor sanitation and inadequate hygiene practices, facilitate the spread of the virus.

Transmission and Risk Factors

The virus spreads primarily through direct contact with infected fecal matter, which can occur due to contaminated water or food. In rare instances, it can also be transmitted via droplets from a sneeze or cough of an infected person. Risk factors include living in areas with low immunization coverage, overcrowding, and lack of access to clean water and sanitation facilities.

---

Symptoms of Poliomyelitis

The clinical presentation of poliomyelitis can range from asymptomatic to severe paralytic disease. Approximately 90% to 95% of infections are asymptomatic, making it difficult to identify and control outbreaks.

Non-paralytic Polio

Non-paralytic polio, which accounts for about 4-8% of cases, presents with mild, flu-like symptoms such as fever, sore throat, headache, vomiting, fatigue, and muscle stiffness. These symptoms typically resolve within a week to ten days without causing lasting effects.

Paralytic Polio

Paralytic polio, the most severe form, affects less than 1% of those infected. The virus invades the anterior horn cells of the spinal cord and the motor cortex of the brain, leading to flaccid paralysis. Initial symptoms mirror those of non-paralytic polio, but within a week, severe muscle pain and spasms precede the onset of paralysis. The paralysis is often asymmetrical, affecting one side of the body more than the other.

---

Diagnosis of Poliomyelitis

Accurate diagnosis of poliomyelitis is crucial for effective management and control of outbreaks. Laboratory tests play an essential role in confirming the presence of the poliovirus.

Laboratory Testing

The most definitive diagnostic test for poliomyelitis is the isolation of the poliovirus from a stool sample. Throat swabs or cerebrospinal fluid (CSF) analysis can also aid in diagnosis, although the virus is less frequently isolated from these samples. Molecular techniques, such as polymerase chain reaction (PCR), can detect viral RNA and provide rapid results.

Differential Diagnosis

Differential diagnosis includes ruling out other causes of acute flaccid paralysis (AFP), such as Guillain-Barré syndrome, transverse myelitis, and acute disseminated encephalomyelitis. A thorough clinical evaluation, alongside laboratory testing, ensures an accurate diagnosis.

---

Management of Poliomyelitis

Management of poliomyelitis focuses on alleviating symptoms and preventing complications, as there is no cure for the disease.

Supportive Care

Supportive care remains the cornerstone of poliomyelitis management. This includes pain relief, physical therapy to prevent deformities, and the use of orthotic devices to support weakened limbs. In severe cases, mechanical ventilation may be necessary if respiratory muscles are affected.

Long-term Management

Post-polio syndrome (PPS) is a condition that affects polio survivors years after recovery, characterized by muscle weakness, fatigue, and joint pain. Long-term management involves comprehensive rehabilitation programs, including physical therapy, occupational therapy, and psychological support, to improve quality of life.

---

Prevention of Poliomyelitis

Vaccination is the most effective means of preventing poliomyelitis. Two vaccines are available: the inactivated poliovirus vaccine (IPV) and the oral poliovirus vaccine (OPV).

Vaccination Strategies

The IPV, administered via injection, is used in most developed countries and provides immunity without the risk of vaccine-derived poliovirus. The OPV, administered orally, is used in mass vaccination campaigns in polio-endemic regions due to its ease of administration and ability to induce mucosal immunity. However, OPV carries a small risk of vaccine-associated paralytic polio (VAPP).

Global Eradication Efforts

The Global Polio Eradication Initiative (GPEI), launched in 1988, has significantly reduced polio incidence worldwide. Through widespread vaccination campaigns and rigorous surveillance, the GPEI aims to eradicate polio completely. Challenges remain, particularly in conflict-affected regions where access to vaccines is limited, but continued international collaboration and investment are crucial to achieving global eradication.